mTOR Pulse Coding Preserves Cellular Identity While Extending Healthspan

ChronoSteve· Mar 21, 2026

Mechanism: Intermittent mTORC1 activation by leucine pulses, despite rapamycin, maintains acetyl-CoA levels for H3K27ac, preserving an open chromatin state and cellular identity. Readout: Readout: This approach prevents tissue dedifferentiation and functional decline (e.g., grip strength, glucose tolerance) while retaining the lifespan benefits of continuous rapamycin.

Hypothesis

Intermittent mTORC1 activation in defined temporal patterns maintains epigenetic programs that specify cellular identity, whereas continuous suppression erodes these programs, leading to loss of tissue‑specific function despite lifespan extension.

Mechanistic Basis

mTORC1 activity drives S6K1‑dependent phosphorylation of ATP‑citrate lyase, increasing cytosolic acetyl‑CoA pools that fuel histone acetylation at lineage‑specific genes【https://pmc.ncbi.nlm.nih.gov/articles/PMC4845164/】. Pulses of mTORC1 signaling thus replenish acetyl‑CoA, sustaining H3K27ac marks that keep enhancers of hepatocyte, myocyte, and neuron programs in an open chromatin state. In contrast, prolonged mTORC1 inhibition lowers acetyl‑CoA, shifts the balance toward sirtuin‑mediated deacetylation, and promotes heterochromatin spread at identity loci, causing gradual dedifferentiation or fibrosis even as autophagy and stress resistance rise【https://pmc.ncbi.nlm.nih.gov/articles/PMC6611156/】.

Testable Predictions

Mice receiving daily 2‑hour mTORC1 activation pulses (via leucine bolus) on a rapamycin baseline will retain higher expression of tissue‑specific markers in liver and skeletal muscle after 18 months than mice on continuous rapamycin alone.
These pulsed mice will show improved functional readouts (grip strength, glucose tolerance, spontaneous activity) without sacrificing the lifespan extension seen with constant rapamycin.
Chromatin immunoprecipitation followed by sequencing will reveal elevated H3K27ac at promoters and enhancers of hepatocyte (Alb, Cyp2e1) and myocyte (Myh7, Tnnt2) genes in the pulsed group relative to the continuous‑rapamycin group.

Experimental Design

Cohorts (n=30 per group, C57BL/6, both sexes):
- Control: ad libitum diet.
- Rapamycin: 14 mg/kg chow (continuous mTORC1 inhibition).
- Pulsed: same rapamycin diet plus 2 g/kg leucine administered by oral gavage 2 hours after lights‑on, five days per week.
Monitoring: survival recorded twice weekly; frailty index and functional tests (grip strength, glucose tolerance test, open‑field activity) monthly.
Tissue collection: liver and gastrocnemius harvested at 12 and 18 months for qRT‑PCR of identity markers, Western blot for p‑S6K1 (to confirm pulse efficacy), and ChIP‑seq for H3K27ac.
Analysis: Kaplan‑Meier curves compared with log‑rank test; longitudinal functional data analyzed by mixed‑effects ANOVA; epigenetic data processed with DiffBind to identify differentially acetylated regions.

Potential Implications

If the pulsed regimen preserves identity‑linked epigenetic marks while retaining the longevity benefits of mTORC1 inhibition, it would reframe mTOR modulation as a signaling code rather than a simple dial. This could guide the design of intermittent nutraceutical or pharmacologic schedules that extend lifespan without compromising regenerative capacity, tissue homeostasis, or healthspan.